TY  - GENERIC
DO  - 10.20944/preprints202408.1985.v1
UR  - http://dx.doi.org/10.20944/preprints202408.1985.v1
TI  - Is Canada Moving towards a More Agile Regulatory Approval and a Reimbursement Process with a Shifting Role for Real-World Evidence (RWE) for Oncology Drugs?
T2  - Preprints
AU  - Lau, Catherine Y
AU  - Rawson, Nigel SB
PY  - 2024
DA  - 2024/08/28
PB  - Preprints